Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, announces that four abstracts featuring ...

VENTURE Study Exploratory Analysis Shows VK2735 Improved Cardiometabolic Parameters After 13 Weeks; Reducing Prediabetes and Metabolic Syndrome SAN DIEGO, Nov. 6, 2025 /PRNewswire/ -- Viking ...

Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...

LA CROSSE, Wis. (WKBT) -- Viterbo University welcomed undergraduate researchers from seven campuses Friday for the Seven ...

Other CIBMTR presentations will include additional results from ACCESS study; a trial in progress update on the ACCELERATE trial (NCT06859424), a platform protocol for testing multiple PTCy-based ...

Union Minister of Science & Technology Dr. Jitendra Singh today lauded the launch of the historic Rs 1 Lakh Crore Research, ...

Presentation details are below: Session Name: Alzheimer's Disease Therapeutic Strategies: Pharmaceutical Approaches Date/Time: November 17, 8 a.m. -12 p.m. PST Session Name: Cellular Stress and ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...

In a moving tribute to the courage, resilience, and service of Indigenous peoples in Canada’s military history, the Milton ...